Morone Giovanni, Claudia Müller-Eising, Bonanno Mirjam, Ciancarelli Irene, Mazzoleni Stefano, Calabrò Rocco Salvatore
Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
San Raffaele Institute of Sulmona, Sulmona, Italy.
Expert Rev Med Devices. 2024 Nov;21(11):999-1006. doi: 10.1080/17434440.2024.2418399. Epub 2024 Oct 23.
Translational medicine has been facing a persistent crisis for decades, and the field of neurorehabilitation is no exception. The challenges and delays that prevent patients, caregivers, and clinicians from promptly benefiting from advancements in bioengineering and new technological discoveries are well-documented.
AREAS-COVERED: This perspective presents some ideas to underline the consolidated problems and highlight new obstacles to overcome in the context of translational neurorehabilitation, also considering the increasingly stringent laws for medical devices that are emerging throughout the world.
The objective of the entire medical-scientific community must be to ensure that patients and their loved ones receive the best care available with the most advanced systems. Bioengineers, healthcare policy makers, certifiers and clinicians must always take translational aspects into consideration and find solutions to mitigate possible problems and delays. The goal of the entire medical and scientific community should be to ensure that patients and their families receive the highest quality care through the most advanced systems. To achieve this, bioengineers, healthcare policymakers, certifiers, and clinicians must consistently address translational challenges and work collaboratively to find solutions that minimize potential problems and delays.
几十年来，转化医学一直面临着持续的危机，神经康复领域也不例外。阻碍患者、护理人员和临床医生迅速从生物工程进展和新技术发现中受益的挑战和延误有充分的文献记载。
本观点文章提出了一些想法，以强调在转化神经康复背景下的既有问题，并突出需要克服的新障碍，同时也考虑到世界各地日益严格的医疗器械法规。
整个医学科学界的目标必须是确保患者及其亲人能够通过最先进的系统获得最佳护理。生物工程师、医疗保健政策制定者、认证机构和临床医生必须始终考虑转化方面的问题，并找到解决方案以减轻可能出现的问题和延误。整个医学和科学界的目标应该是确保患者及其家人通过最先进的系统获得最高质量的护理。为实现这一目标，生物工程师、医疗保健政策制定者、认证机构和临床医生必须持续应对转化挑战，并共同努力找到将潜在问题和延误降至最低的解决方案。
